Figure 3
aHRs and 95% CIs for Product D vs Product E of the RODIN and the FranceCoag studies and combined aHRs between both studies for all inhibitors and high-titer inhibitors outcomes.
aHRs and 95% CIs for Product D vs Product E of the RODIN and the FranceCoag studies and combined aHRs between both studies for all inhibitors and high-titer inhibitors outcomes.
